Search clinical trials for: subcutaneous infusion

Total 7120 results

Biocad

Recruiting

Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

Axial Spondyloarthritis

Russian Federation, Belarus
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Radial Artery Occlusion

China
The First Affiliated Hospital with Nanjing Medical...
Huai'an First People's Hospital; Yancheng First People's Hospital

Recruiting

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Acute Myeloid Leukemia

China
AbbVie

Recruiting

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease (ROSSINI)

Parkinson's Disease (PD)

Germany, Denmark, Spain
University Hospital, Toulouse
Orkyn'; ELIVIE France; EVER Pharma France SAS; NHC SAS, France; ETPARK Association...

Recruiting

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease (PERSO-PERF)

Parkinson Disease

France
National Taiwan University Hospital
China Medical University Hospital; Kaohsiung Medical University Chung-Ho Memorial... and other collaborators

Not yet recruiting

Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

Early Syphilis, Latent, Serological Relapse After Treatment
Bayer

Recruiting

A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Pulmonary Hypertension Due to Left Heart Disease

Germany
Mayo Clinic

Not yet recruiting

Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
AbbVie

Recruiting

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

Parkinson's Disease (PD)

Japan
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases (PID)

United States
First Affiliated Hospital of Guangxi Medical University

Recruiting

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Type2diabetes

China
Assistance Publique Hopitaux De Marseille

Recruiting

Development of a Proactive Health Care Pathway When Initiating Continuous Subcutaneous Apomorphine Infusion in Patients With Parkinson Disease : Impact on Their Autonomy (AUTAP) (AUTAP)

Parkinson Disease

France
Gruppo Oncologico del Nord-Ovest
Seagen Inc.; Servier; Foundation Medicine

Recruiting

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients (ERASE-CRC)

Stage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon Cancer

Italy
University of British Columbia

Recruiting

Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain

Acute Pain | Cardiac Surgery | Sternotomy

Canada
Peking University Third Hospital

Not yet recruiting

CSII Versus MDI in Pregnant Women With Type 2 Diabetes

Type 2 Diabetes | Pregnancy in Diabetic

China
VitalAire

Not yet recruiting

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life (IMPLIQUE)

Quality of Life | Burden, Dependency
Rennes University Hospital

Recruiting

Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease (PHARM-APO)

Parkinson Disease

France
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes (DSS-2)

Diabetes Mellitus, Type 1

United States
University Hospital, Montpellier
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia (DCLP2)

Type 1 Diabetes Mellitus With Hypoglycemia

France
Hospital for Special Surgery, New York
GlaxoSmithKline

Recruiting

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Systemic Sclerosis

United States
Medical University of Graz

Recruiting

Inflammatory Response to CSII Catheters in a Tummy Tuck Model (IRCATT)

Diabetes Mellitus

Austria
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaborators

Recruiting

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
American Society of Clinical Oncology
Bristol-Myers Squibb; Eli Lilly and Company; Bayer; Merck Sharp & Dohme LLC; Pfizer; AstraZene... and other collaborators

Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer (TAPUR)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid Tumors

United States
University of Cambridge
The Leeds Teaching Hospitals NHS Trust; Cambridge University Hospitals NHS... and other collaborators

Active, not recruiting

Closed Loop From Onset in Type 1 Diabetes (CLOuD)

Diabetes Mellitus | Type 1 Diabetes

United Kingdom
Takeda

Active, not recruiting

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Crohn's Disease | Colitis, Ulcerative

United States, Belgium, Israel, Spain, Korea, Republic of, Taiwan, Netherlands, Australia, Denmark, Hungary, Italy, Russian Federation, Brazil, Croatia, Germany, Serbia, Bulgaria, Canada, Poland, Slovakia, Ukraine, Czechia, Argentina, Turke... and more
Janssen Research & Development, LLC

Active, not recruiting

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (GRAVITI)

Crohn Disease

Belgium, United States, Japan, Czechia, Hungary, Korea, Republic of, France, Taiwan, Germany, Malaysia, New Zealand, Poland, Canada, Turkey, Croatia, Israel, China, Denmark, Netherlands, Brazil, Italy, Spain, Jordan, Bosnia and Herzegovina and more
Imperial College London
London Ambulance Service

Terminated

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia (AIR-CGM)

Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United Kingdom
Baxalta now part of Shire

Completed

A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Primary Immunodeficiency Diseases (PID)

Japan
University Medical Center Groningen

Terminated

Treatment of Apomorphine-induced Skin Reactions: a Pilot Study

Parkinson's Disease | Apomorphine-induced Skin Reactions

Netherlands
Haukeland University Hospital

Terminated

Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes

Type 1 Diabetes | Addison Disease

Norway
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Myelodysplastic Syndromes | Myeloproliferative Neoplasm

United States
Nemours Children's Clinic
Patient-Centered Outcomes Research Institute

Completed

Shared Medical Decision Making in Pediatric Diabetes

Type 1 Diabetes Mellitus

United States
City of Hope Medical Center
Sangamo Therapeutics; California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

HIV

United States
Merck Sharp & Dohme LLC

Completed

Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

Melanoma

Australia, South Africa, Spain, Sweden
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants

Healthy Volunteers

United States
AbbVie

Active, not recruiting

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
Marc Breton
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery (Rocket-BPS)

Type 1 Diabetes

United States
AbbVie

Active, not recruiting

Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia
AbbVie

Terminated

A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease (AIM-CD)

Crohn's Disease

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Slovakia, Spain, Taiwan, United...
Damanhour University

Completed

Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients

Sepsis | Critical Illness

Egypt
University of Florida

Completed

Skeletal Muscle and Adipose Tissue Study

Idiopathic Scoliosis

United States
Nemours Children's Clinic

Completed

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

Diabetes Mellitus, Insulin-Dependent

United States
Gianna Wilkie

Completed

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Type 1 Diabetes | Pregnancy, High Risk

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; HIV Prevention Trials Network

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

HIV Infections

United States
Eli Lilly and Company

Completed

A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Jewish General Hospital

Terminated

Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

Pulmonary Arterial Hypertension

Canada
AbbVie

Completed

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
University Hospital, Caen

Completed

Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes

Type 2 Diabetes Mellitus
Arecor Limited

Completed

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Diabetes Mellitus, Type 1

United States

Search clinical trials for: subcutaneous infusion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations